TAE Life Sciences (TLS) products

TAE Life Sciences is committed to developing a portfolio of novel targeted boron drugs to expand the application of BNCT to other cancer types and to provide even better outcomes for indications historically treated with Boronophenylalanine (BPA), a boron delivery drug.

TLS’s Alphabeam System includes a compact tandem accelerator-based neutron source and other hardware and software components to provide a complete BNCT solution. Our system is designed to be installed in a hospital setting and can be configured in a single or multi-room BNCT center to meet your clinical, research, and capacity needs. Treatment rooms includes fixed beam, beam shaping assembly, and a ceiling-mounted robotic couch for optimal patient positioning.